| Surgery Name | Cost | Room | Hospitalization |
|---|---|---|---|
| Bone Marrow Transplant | USD 26000 - USD 30000 | Private | 4 weeks |
The Only Established Curative Treatment for Thalassemia Major - With an 85-90% Success Rate at Top JCI and NABH Accredited Hospitals
Thalassemia Major (also called Beta Thalassemia Major or Cooley Anemia) is an inherited genetic blood disorder in which the body cannot produce adequate healthy hemoglobin. Children born with this condition develop severe anemia within the first two years of life and become dependent on blood transfusions every 2-4 weeks for survival. Repeated transfusions cause iron overload, which progressively damages the heart, liver and endocrine glands. Without curative treatment, patients face lifelong transfusions, iron chelation therapy and reduced life expectancy.
Allogeneic Bone Marrow Transplant (BMT), also known as Stem Cell Transplant, is the only established curative treatment for Thalassemia Major. In an MSD BMT, healthy blood-forming stem cells are collected from a brother or sister who is a full HLA match with the patient. The defective bone marrow of the patient is first eliminated using a conditioning chemotherapy regimen (commonly Thiotepa, Treosulfan and Fludarabine), after which the donor stem cells are infused. The new marrow starts producing healthy red blood cells, permanently freeing the patient from blood transfusions.
A fully matched sibling donor offers the highest cure rates and the lowest risk of complications such as graft rejection and Graft Versus Host Disease (GVHD), which is why MSD BMT is considered the gold standard for curing Thalassemia Major.
Before the transplant, a detailed evaluation is performed to establish disease status, assess iron overload and organ damage, and confirm donor suitability. The evaluation is done on OPD basis, usually takes 7-10 days, and costs approximately USD 1,500 - 2,000. It includes:
HLA (Human Leukocyte Antigen) typing is a blood test that identifies genetic markers used to match the patient with a donor. For the best outcome, a 10/10 fully matched donor is preferred. Each biological sibling has a 25% chance of being a complete HLA match with the patient, which is why high resolution HLA typing of the patient and all siblings is the first step.
The donor undergoes fitness evaluation and viral screening. Stem cells are collected from the donor either from bone marrow under anesthesia or from peripheral blood after growth factor injections. The donor typically needs only 1 day of admission and recovers fully within a few days.
| Particulars | Details |
|---|---|
| Disease Evaluation and Pre-Transplant Workup (OPD) | USD 1,500 - 2,000 Approx. |
| Matched Sibling Donor Allogeneic BMT Package | USD 26,000 - 30,000 Approx. |
| Hospital Stay | 22-28 Days (Patient) + 1 Day (Donor) |
| Total Stay in India | 2-3 Months Approx. |
Packages generally include transplant for the patient, stem cell collection and harvesting from the donor, investigations, pharmacy, consumables, blood bank support and hospital stay as per protocol. ICU stay, unrelated complications, stay beyond package days and post-discharge medicines are charged additionally.
| Country | Approximate Cost (USD) |
|---|---|
| India | 26,000 - 30,000 |
| USA | 250,000 - 400,000 |
| UK | 200,000 - 300,000 |
| Singapore | 150,000 - 200,000 |
| Turkey | 60,000 - 80,000 |
Patients save up to 85-90% of the treatment cost in India without any compromise on quality, as the transplants are performed at JCI and NABH accredited hospitals by internationally trained BMT specialists.
With a fully matched sibling donor, the success rate of BMT for Thalassemia Major in India is 85-90%. Outcomes are best when the transplant is done at a younger age, before severe iron overload and organ damage develop. Once the graft is stable and chimerism is complete, the patient is considered cured - no more transfusions, no more chelation therapy, and a normal quality of life.
A fully HLA matched sibling (brother or sister) is the best donor, offering an 85-90% cure rate with the lowest risk of rejection and GVHD. Each sibling has a 25% chance of being a full match.
The transplant package costs approximately USD 26,000 - 30,000, plus USD 1,500 - 2,000 for disease evaluation and pre-transplant workup including HLA typing.
The hospital stay is 22-28 days for the transplant, and the total stay in India is around 2-3 months including evaluation and post-transplant OPD follow-up.
Yes. Allogeneic BMT is the only established curative treatment for Thalassemia Major. After successful engraftment, the patient becomes permanently free from blood transfusions and iron chelation.
A matched unrelated donor can be searched in international registries (2-3 months search time), or a haploidentical transplant can be done using a parent as the donor with approximately 70% success. Our team helps the family choose the safest option.
Send us the medical reports and HLA typing results (if available) on WhatsApp and receive free opinions and package quotes from the top BMT hospitals in India within 24-48 hours.
Satyug Healthcare - Trusted Medical Tourism Partner for Patients from 30+ Countries
